More on ACRV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.1 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Acrivon Therapeutics (NQ:ACRV)
Delayed: 1.57 +0.05 (3.29%)
Prev. Close $1.52  
Open$1.54 
52 Wk High$ 
52 Wk Low$ 
Day High$1.61 
Day Low$1.51 
P/E N/A  
EPS$ 
Volume713,722 

Friends, Peers and Foes (?): INCY, ACET, ARVN, AZN, BCAB (more...)

Jun 17, 2026 05:28 PM Form 8-K Acrivon Therapeutics, For: Jun 17
Jun 10, 2026 05:19 AM Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK
May 26, 2026 04:19 PM Form 4 Acrivon Therapeutics, For: May 21 Filed by: Blume-Jensen Peter
May 22, 2026 04:06 PM Form DEFA14A Acrivon Therapeutics,
May 21, 2026 07:30 AM Acrivon Therapeutics to Present at TD Cowen’s 7th Annual Oncology Innovation Summit
May 20, 2026 05:00 PM Form 4 Acrivon Therapeutics, For: May 18 Filed by: Shah Rajeev M.
May 20, 2026 04:37 PM Form 4 Acrivon Therapeutics, For: May 18 Filed by: TOMSICEK MICHAEL JOHN
May 20, 2026 04:36 PM Form 4 Acrivon Therapeutics, For: May 18 Filed by: Shacham Sharon
May 20, 2026 04:36 PM Form 4 Acrivon Therapeutics, For: May 18 Filed by: Palani Santhosh
May 20, 2026 04:35 PM Form 4 Acrivon Therapeutics, For: May 18 Filed by: Magovcevic-Liebisch Ivana
View All Articles

Entities mentioned with ACRV

View All Entities